论文部分内容阅读
目的探讨儿童支原体肺炎经小儿肺热咳喘口服液结合阿奇霉素治疗后的临床疗效。方法选取我院76例支原体肺炎患儿参与本次研究,收治时间在2014年1月至2016年5月间,根据随机抽签法平分为实验组、对照组各38例,对照组采取阿奇霉素治疗;实验组接受小儿肺热咳喘口服液结合阿奇霉素治疗;对比两组患儿治疗效果。结果观察组总有效率为92.1%高于对照组患儿的76.3%;且前者的临床症状、体征时间均优于对照组,(P<0.05)。结论儿童支原体肺炎实施小儿肺热咳喘口服液结合阿奇霉素治疗后可有效改善患儿临床症状,提高治疗效果,可在临床上加以推及。
Objective To investigate the clinical efficacy of children’s Mycoplasma pneumonia after oral administration of Hyperactivity Kechuan oral solution combined with azithromycin. Methods A total of 76 mycoplasmal pneumonia children were enrolled in this study. The treatment time ranged from January 2014 to May 2016 according to the random lottery method. The control group was divided into experimental group and control group with 38 cases each. The control group was treated with azithromycin. The experimental group received pediatric Hyperactivity Kechuan oral liquid combined with azithromycin treatment; compared two groups of children treatment effect. Results The total effective rate was 92.1% in the observation group and 76.3% in the control group. The clinical symptoms and signs of the former were better than those in the control group (P <0.05). Conclusion Mycoplasma pneumonia in children with pulmonary Hyperactivity Kechuang oral solution combined with azithromycin treatment can effectively improve the clinical symptoms of children and improve the treatment effect can be pushed to the clinic.